Advertisement

Scarlet Fever

  • Nathaniel Johnson
  • James Dill
Chapter

Abstract

Scarlet fever is a dermatological complication of streptococcal pharyngitis and GAS skin infections. This chapter seeks to characterize the clinical presentation, as well as describe the treatment and complications. This chapter will also discuss some of the common mimics of scarlet fever. The goal of this chapter is to give an understanding the urgencies and emergencies of scarlet fever, and its management, for the health-care professional.

Keywords

Scarlet fever Pharyngitis Strep throat Maculopapular rash Group A Streptococcus 

References

  1. 1.
    Shulman ST, Bisno AL, Clegg HW, et al. Clinical practice guideline for the diagnosis and management of group A streptococcal pharyngitis: 2012 update by the Infectious Diseases Society of America. Clin Infect Dis. 2012;55(10):1279–82.CrossRefPubMedGoogle Scholar
  2. 2.
    McIsaac WJ, Kellner JD, Aufricht P, Vanjaka A, Low DE. Empirical validation of guidelines for the management of pharyngitis in children and adults. JAMA. 2004;291(13):1587–95.CrossRefPubMedGoogle Scholar
  3. 3.
    “Scarlet Fever: a group A Streptococcal infection”. Center for Disease Control and Prevention. 19 Jan 2016.Google Scholar
  4. 4.
    Pichichero ME. “Complications of streptococcal tonsillopharyngitis”. UpToDate. 4 Feb 2016.Google Scholar
  5. 5.
    Bisno AL, Gerber MA, Gwaltney JM Jr, Kaplan EL, Schwartz RH. Practice guidelines for the diagnosis and management of group A streptococcal pharyngitis. Infectious Diseases Society of America. Clin Infect Dis. 2002;35:113–25.CrossRefPubMedGoogle Scholar
  6. 6.
    Meier FA, Centor RM, Graham L Jr, Dalton HP. Clinical and microbiological evidence for endemic pharyngitis among adults due to group C streptococci. Arch Intern Med. 1990;150:825–9.CrossRefPubMedGoogle Scholar
  7. 7.
    Zabriskie JB. The role of temperate bacteriophage in the production of erythrogenic toxin by Group A Streptococci. J Exp Med. 1964;119(5):761–80. PMC 2137738. PMID 14157029.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Martin JM, Green M, Barbadora KA, Wald ER. Group A streptococci among school-aged children: clinical characteristics and the carrier state. Pediatrics. 2004;114:1212–9.CrossRefPubMedGoogle Scholar
  9. 9.
    Kellogg JA. Suitability of throat culture procedures for detection of group A streptococci and as reference standards for evaluation of streptococcal antigen detection kits. J Clin Microbiol. 1990;28:165–9.PubMedPubMedCentralGoogle Scholar
  10. 10.
    Bisno AL. Acute pharyngitis: etiology and diagnosis. Pediatrics. 1996;97:949–54.PubMedGoogle Scholar
  11. 11.
    Wannamaker LW. Perplexity and precision in the diagnosis of streptococcal pharyngitis. Am J Dis Child. 1972;124:352–8.PubMedGoogle Scholar
  12. 12.
    Gerber MA. Diagnosis of pharyngitis: methodology of throat cultures. In: Shulman ST, editor. Pharyngitis: management in an era of declining rheumatic fever. New York: Praeger; 1984. p. 61–72.Google Scholar
  13. 13.
    Schwartz RH, Gerber MA, McCoy P. Effect of atmosphere of incubation on the isolation of group A streptococci from throat cultures. J Lab Clin Med. 1985;106:88–92.PubMedGoogle Scholar
  14. 14.
    Centor RM, Geiger P, Waites KB. Fusobacterium necrophorum bacteremic tonsillitis: 2 cases and a review of the literature. Anaerobe. 2010;16:626–8.CrossRefPubMedGoogle Scholar
  15. 15.
    Tanz RR, Gerber MA, Kabat W, Rippe J, Seshadri R, Shulman ST. Performance of a rapid antigen-detection test and throat culture in community pediatric offices: implications for management of pharyngitis. Pediatrics. 2009;123:437–44.CrossRefPubMedGoogle Scholar
  16. 16.
    Gerber MA, Shulman ST. Rapid diagnosis of pharyngitis caused by group A streptococci. Clin Microbiol Rev. 2004;17:571–80.CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Shet A, Kaplan EL. Clinical use and interpretation of group a streptococcal antibody tests: a practical approach for the pediatrician or primary care physician. Pediatr Infect Dis J. 2002;21:420–6; quiz 27–30.CrossRefPubMedGoogle Scholar
  18. 18.
    Johnson DR, Kurlan R, Leckman J, Kaplan EL. The human immune response to streptococcal extracellular antigens: clinical, diagnostic, and potential pathogenetic implications. Clin Infect Dis. 2010;50:481–90.CrossRefPubMedGoogle Scholar
  19. 19.
    “About Kawasaki Disease”. Center for Disease Control and Prevention. 13 Dec 2013.Google Scholar
  20. 20.
    “Kawasaki Disease”. PubMed Health. NHLBI Health Topics. 11 June 2014. Retrieved 26 Aug 2016.Google Scholar
  21. 21.
    Logan LK, McAuley JB, Shulman ST. Macrolide treatment failure in streptococcal pharyngitis resulting in acute rheumatic fever. Pediatrics. 2012;129:e798; originally published online February 6, 2012.  https://doi.org/10.1542/peds.2011-1198.CrossRefPubMedGoogle Scholar
  22. 22.
    McIsaac W, White D, Tannenbaum D, Low D. A clinical score to reduce unnecessary antibiotic use in patients with sore throat. Can Med Assoc J. 1998;158(1):75–83.Google Scholar
  23. 23.
    Del Mar CB, Glasziou PP, Spinks AB. Antibiotics for sore throat. Cochrane Database Syst Rev. 2006;(4):CD000023.Google Scholar
  24. 24.
    Lee GM, Wessels MR. Changing epidemiology of acute rheumatic fever in the United States. Clin Infect Dis. 2006;42(4):448–50.CrossRefPubMedGoogle Scholar
  25. 25.
    Cunningham MW. Pathogenesis of group A streptococcal infections. Clin Microbiol Rev. 2000;13(3):470–511.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Emergency Medicine/PediatricsUniversity of ArizonaTucsonUSA

Personalised recommendations